IPRF Suggests Global Template for Sharing Biosimilar Assessment Data
This article was originally published in SRA
Executive Summary
The International Pharmaceutical Regulators Forum has come up with a draft template that it says should help national regulatory bodies produce a standardized English-language summary of their assessments of biosimilar medicines1.